FDA NDC
AMJEVITA
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 84612-399
- Proprietary name
- AMJEVITA
- Nonproprietary name
- adalimumab-atto
- Labeler
- Nuvaila Limited
- Dosage form
- INJECTION
- Strength
- 20 mg/.2mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted adalimumab-atto?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.